Nosocomial infection by trimethoprim/sulfamethoxazole resistant s senotrophomonas maltophilia in intensive care units of Mansoura university hospitals
EJMM-Egyptian Journal of Medical Microbiology [The]. 2011; 20 (1): 91-98
in English
| IMEMR
| ID: emr-195456
ABSTRACT
Background:
trimethoprim/sulfamethoxazole [['MPISMX] has been the antimicrobial of choice for treatment of Stenotrophomonas malt philia [S. malt philia] infections. Several reports have shown that the prevalence of strains resistant to TMP/SMX is increasing. We investigated prevalence, risk factors and sulfamethoxazole resistance determinants of TMPISMX resistant S. malt philia in our geographic location
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Language:
English
Journal:
Egypt. J. Med. Microbiol.
Year:
2011
Similar
MEDLINE
...
LILACS
LIS